Is chemotherapy really the best option in older adults with acute myeloid leukemia?
- 1 October 2013
- journal article
- Published by Future Medicine Ltd in International Journal of Hematologic Oncology
- Vol. 2 (5), 355-358
- https://doi.org/10.2217/ijh.13.44
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survivalBlood, 2013
- Outcome of older patients with acute myeloid leukemiaCancer, 2013
- Acute myeloid leukaemia in adultsThe Lancet, 2013
- Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trialLeukemia, 2012
- Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemiaBlood, 2012
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid LeukemiaJournal of Clinical Oncology, 2012
- Acute myeloid leukemia in older adultsInternational Journal of Hematology, 2012
- Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I TrialJournal of Clinical Oncology, 2012
- Treatment of Unfit Patients With Acute Myeloid Leukemia: A Still Open Clinical ChallengeClinical Lymphoma Myeloma and Leukemia, 2011
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid LeukemiaJournal of Clinical Oncology, 2010